Sodium Bicarbonate Injection Market

It is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis.

Sodium Bicarbonate Injection Market contains market size and forecasts of Sodium Bicarbonate Injection in global, including the following market information:

• Global Sodium Bicarbonate Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Sodium Bicarbonate Injection Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Sodium Bicarbonate Injection companies in 2021 (%)

The global Sodium Bicarbonate Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.042 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sodium Bicarbonate Injection include Amphastar, Pfizer, Athenex, Exela, Fresenius Kabi, B Braun, Phebra, Livealth Biopharma and Hunan Jinjian Yaoye, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Sodium Bicarbonate Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sodium Bicarbonate Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sodium Bicarbonate Injection Market Segment Percentages, by Type, 2021 (%)

• 0.042
• 0.084

Global Sodium Bicarbonate Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sodium Bicarbonate Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialty Clinic
• Recovry Center

Global Sodium Bicarbonate Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sodium Bicarbonate Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Sodium Bicarbonate Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Sodium Bicarbonate Injection revenues share in global market, 2021 (%)
• Key companies Sodium Bicarbonate Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Sodium Bicarbonate Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amphastar
• Pfizer
• Athenex
• Exela
• Fresenius Kabi
• B Braun
• Phebra
• Livealth Biopharma
• Hunan Jinjian Yaoye
• Kelun Pharma
• Brilliant Pharmaceutical Group
• Huarun Double-Crane
• Zhejiang Conba Pharmaceutical